Targeting inflammation in atherosclerosis — from experimental insights to the clinic
Oliver SoehnleinDepartment of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden. [email protected]Peter LibbyBrigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
2021en
ABI
Abstract
No abstract available.
Identifiers
Citations and references
Cited by 20 references